We provide an overview of the role ofAMPK in cancer and the developmentof small molecule modulators of AMPK activity and summarize the indirectand direct AMPK activators and emergent AMPK inhibitors and the challengesof developing these agents as therapeutics. This evidence concerns the gene PRKAA2 and cancer.